Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems

Nano Letters

Volumn 6, Issue 11, 2006, Pages 2427-2430

  Nasongkla, Norased ^a   Bey, Erik ^a   Ren, Jimin ^b   Ai, Hua ^a   Khemtong, Chalermchai ^a   Guthi, Jagadeesh Setti ^a   Chin, Shook Fong ^a   Sherry, A Dean ^b   Boothman, David A ^a   Gao, Jinming ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; INTEGRINS; POLYMERIC MICELLES; SUPERPARAMAGNETIC IRON OXIDE (SPIO);

CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; MAGNETIC RESONANCE IMAGING; ONCOLOGY; POLYMERS; TUMORS;

MICELLES;

ARGINYL-GLYCYL-ASPARTIC ACID; ARGINYLGLYCYLASPARTIC ACID; DOXORUBICIN; FERRIC ION; FERRIC OXIDE; LIGAND; NANOPARTICLE; OLIGOPEPTIDE; POLYMER; VITRONECTIN RECEPTOR;

ARTICLE; CELL PROLIFERATION; CHEMISTRY; COMPARATIVE STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFECT; HUMAN; MICELLE; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; PH; SENSITIVITY AND SPECIFICITY; STRUCTURE ACTIVITY RELATION; SURFACE PROPERTY; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FERRIC COMPOUNDS; HUMANS; HYDROGEN-ION CONCENTRATION; INTEGRIN ALPHAVBETA3; LIGANDS; MAGNETIC RESONANCE IMAGING; MICELLES; NANOPARTICLES; NEOPLASMS; OLIGOPEPTIDES; POLYMERS; SENSITIVITY AND SPECIFICITY; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PROPERTIES;

EID: 33846160552     PISSN: 15306984     EISSN: None     Source Type: Journal    
DOI: 10.1021/nl061412u     Document Type: Article

References (21)

1. Li, K. C.; Pandit, S. D.; Guccione, S.; Bednarski, M. D. Biomed. Microdevices 2004, 6, 113-6.
2. Moghimi, S. M.; Hunter, A. C.; Murray, J. C. FASEB J. 2005, 19, 311-30.
3. Kwon, G. S. Crit. Rev. Ther. Drug Carrier Syst. 2003, 20, 357-403.
4. Otsuka, H.; Nagasaki, Y.; Kataoka, K. Adv. Drug Delivery Rev. 2003, 55, 403-419.
5. Torchilin, V. P. J. Controlled Release 2001, 73, 137-72.
6. Danson, S.; Ferry, D.; Alakhov, V.; Margison, J.; Kerr, D.; Jowle, D.; Brampton, M.; Halbert, G.; Ranson, M. Br. J. Cancer 2004, 90, 2085-91.
7. Shuai, X.; Ai, H.; Nasongkla, N.; Kim, S.; Gao, J. J. Controlled Release 2004, 95, 415-26.
8. Matsumura, Y.; Hamaguchi, T.; Ura, T.; Muro, K.; Yamada, Y.; Shimada, Y.; Shirao, K.; Okusaka, T.; Ueno, H.; Ikeda, M.; Watanabe, N. Br. J. Cancer 2004, 91, 1775-81.
9. Yamamoto, Y.; Nagasaki, Y.; Kato, Y.; Sugiyama, Y.; Kataoka, K. J. Controlled Release 2001, 77, 27-38.
10. Varner, J. A.; Cheresh, D. A. Curr. Opin. Cell Biol. 1996, 8, 724-30.
11. Hood, J. D.; Bednarski, M.; Frausto, R.; Guccione, S.; Reisfeld, R. A.; Xiang, R.; Cheresh, D. A. Science 2002, 296, 2404-7.
12. Nasongkla, N.; Shuai, X.; Ai, H.; Weinberg, B. D.; Pink, J.; Boothman, D. A.; Gao, J. Angew. Chem., Int. Ed. 2004, 43, 6323-7.
13. Sun, S.; Zeng, H. J. Am. Chem. Soc. 2002, 124, 8204-5.
14. Shuai, X. T.; Ai, H.; Nasongkla, N.; Kim, S.; Gao, J. M. J. Controlled Release 2004, 98, 415-426.
15. Ai, H.; Flask, C.; Weinberg, R.; Shuai, X.; Pagel, M.; Farrell, D.; Duerk, J.; Gao, J. Adv. Mater. 2005, 17, 1949-1952.
16. Rader, C.; Popkov, M.; Neves, J. A.; Barbas, C. F., III. FASEB J. 2002, 16, 2000-2.
17. Savic, R.; Luo, L.; Eisenberg, A.; Maysinger, D. Science 2003, 300, 615-8.
18. Samaniego, F.; Young, D.; Grimes, C.; Prospero, V.; Christofidou- Solomidou, M.; DeLisser, H. M.; Prakash, O.; Sahin, A. A.; Wang, S. Cell Growth Differ. 2002, 13, 387-95.
19. Burke, T. G.; Morin, M. J.; Sartorelli, A. C.; Lane, P. E.; Tritton, T. R. Mol. Pharm. 1987, 31, 552-6.
20. Zunino, F.; Capranico, G. Anti-Cancer Drug Des. 1990, 5, 307-17.
21. Kim, T. Y.; Kim, D. W.; Chung, J. Y.; Shin, S. G.; Kim, S. C.; Heo, D. S.; Kim, N. K.; Bang, Y. J. Clin. Cancer Res. 2004, 10, 3708-3716.